Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.
Mannan
P
P
Kibbler
C C
CC
Noone
P
P
D000380:Agranulocytosis / Q000382:microbiology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009503:Neutropenia / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000382:microbiology / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D002939:Ciprofloxacin; D003091:Colistin